ICU study tests which heart drug works best when kidneys are struggling
NCT ID NCT07186062
Summary
This study compared three different intravenous heart medications (Levosimendan, Dobutamine, and Milrinone) in 60 critically ill patients. The patients had sudden, severe worsening of heart failure combined with reduced kidney function. Researchers measured which drug best improved heart and kidney performance, length of hospital stay, and survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE (ADHF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
faculty of medicine Ain shams University
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.